Telotristat Etiprate Demonstrates Clinical Benefit in Phase III Carcinoid Syndrome Study October 01, 2015Vol.38 No.09
Cyramza Increases PFS In Phase II Study of Bladder Cancer Patients Who Failed Platinum Therapy October 01, 2015Vol.38 No.09
Two NEJM Papers Evaluate Imetelstat in Myelofibrosis and Essential Thrombocythemia October 01, 2015Vol.38 No.09
Additional Analyses Show Custirsen Lowered Serum Clusterin Levels in CRPC Patients October 01, 2015Vol.38 No.09
Avastin Biosimilar Meets Phase III Endpoints, Demonstrating Clinical Equivalence in Lung Cancer October 01, 2015Vol.38 No.09
Drugs & Targets European Commission Approves Unituxin In Pediatric High-Risk Neuroblastoma August 31, 2015Vol.38 No.08
Oral Telotristat Etiprate Meets Primary Endpoint in Phase III Carcinoid Syndrome Trial August 31, 2015Vol.38 No.08
